Little Health Law Blog
Our healthcare and business law firm advises many physicians, advanced practice registered nurses (APRNs), and medical practices that utilize nurse protocol agreements on Georgia regulatory compliance. A question we frequently receive from urgent care clinics and other episodic-care practices is whether the quarterly physician evaluation requirement under a nurse protocol agreement obligates a practice to recall a patient who received only a single, short-term controlled substance prescription for an acute condition, with no ongoing course of treatment. The Georgia Composite Medical Board (“GCMB”) recently addressed this scenario directly in response to an inquiry from our firm, and this post walks through that clarification and what it means for practices. If you would like to discuss this clarification or would like to discuss this blog post, you may contact our healthcare and business law firm at (404) 685-1662 (Atlanta) or (706) 722-7886 (Augusta), or by email, info@littlehealthlaw.com. You may also learn more about our law firm by visiting www.littlehealthlaw.com.
(1) The Quarterly Evaluation Requirement
Under O.C.G.A. § 43-34-25(c)(9) and GCMB Rule 360-32-.02(5)(d), a delegating or designated physician who authorizes an APRN to prescribe controlled substances pursuant to a nurse protocol agreement must ensure that the patient receives a physician evaluation at least quarterly, with, according to the Medical Board, at least one of those evaluations conducted in person.
(2) The Recurring Question for Acute-Care Practices
For practices structured around episodic or urgent care, this ambiguity raises a practical concern: if an NP prescribes a short-term course of a controlled substance for an acute condition, and the patient is otherwise discharged with no further planned treatment, does the quarterly evaluation requirement obligate the practice to recall that patient for a physician evaluation solely to remain in compliance? Practices have understandably been cautious in the absence of clear guidance, given the potential licensing exposure for both the physician and the NP if the requirement is read literally.
(3) The Board’s Response
Little Health Law raised this scenario directly with GCMB Legal Services. The Board responded the quarterly physician evaluation requirement is intended to apply where a patient continues to receive controlled substances pursuant to a nurse protocol agreement — not to require an otherwise discharged patient to return solely to satisfy the quarterly examination requirement after a single, short-term prescription for an acute condition.
According to the Board, if the patient receives no additional controlled substance prescriptions under the protocol and has no ongoing course of treatment with the practice, there is no expectation that the patient be recalled solely for a quarterly evaluation. For patients who do continue to receive controlled substances under the protocol, the delegating or designated physician remains responsible for ensuring the statutory and regulatory evaluation schedule is met, including at least one in-person evaluation each quarter.
(4) Open Considerations for Practices
The Board frames this interpretation as consistent with the underlying purpose of the statute and rule — physician oversight of ongoing controlled substance management, rather than a blanket recall obligation for isolated acute encounters. That said, several practical questions remain for practices to work through in applying this guidance to their own protocols, including how a practice documents that a patient has in fact been discharged with no anticipated further CS prescribing, how ongoing course of treatment should be defined within an individual nurse protocol agreement, and how these determinations should be reflected in the practice’s recordkeeping in the event of a future licensing board inquiry.
If you would like to discuss quarterly physician evaluation requirements, nurse protocol agreements, or controlled substance prescribing compliance for your practice, or would like to discuss this blog post, you may contact our healthcare and business law firm at (404) 685-1662 (Atlanta) or (706) 722-7886 (Augusta), or by email, info@littlehealthlaw.com. You may also learn more about our law firm by visiting www.littlehealthlaw.com.